Baseline diabetic knowledge after 5-day teaching program is an independent predictor of subclinical macroangiopathy in patients with type 1 diabetes (Poznan Prospective Study)

Advances in Medical Sciences

Volumn 59, Issue 2, 2014, Pages 240-244

  Araszkiewicz, Aleksandra ^a   Zozulinska Ziolkiewicz, Dorota ^a   Pilacinski, Stanislaw ^a   Naskret, Dariusz ^a   Uruska, Aleksandra ^a   Wierusz Wysocka, Bogna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Education; Intensive functional insulin therapy; Intima media thickness; Macroangiopathy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; DIABETES EDUCATION; DIABETIC NEPHROPATHY; DIABETIC PATIENT; ECHOGRAPHY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PROSPECTIVE STUDY; SMOKING; TEACHING; TRAINING; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

EID: 84908454638     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2013.12.005     Document Type: Article

References (27)

1. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, et al. The British Diabetic Association Cohort Study II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;16(June (6)):466-71.
2. Soedamah-Muthua SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe. Diabetes Care 2004;27(February (2)):530-7.
3. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003;26(May (5)):1374-9.
4. The EDIC Research Group. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Diabetes 1999;48(February (2)):383-90.
5. De Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004;109(June (23 (Suppl. 1))):III33-38.
6. Järvisalo MJ, Putto-Laurila A, Jartti L, Lehtimäki T, Solakivi T, Rönnemaa T, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 2002;51(February (2)):493-8.
7. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y, et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 1994;43(May (5)): 634-9.
8. Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 1996;45(September (9)):1253-8.
9. DCCT Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(September (14)):977-86.
10. The EDIC Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a longterm follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22(January (1)):99-111.
11. Sämann A, Mühlhauser I, Bender R, Kloos Ch, Müller UA. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 2005;48(October (10)):1965-70.
12. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. BMJ 2002;325(October):746-9.
13. Araszkiewicz A, Zozulinska-Ziolkiewicz D, Trepinska M, Wierusz-Wysocka B. Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications. Diabetes Res Clin Pract 2008;81(July (1)):61-7.
14. Jörgens V, Grüsser M, Bott U, Mühlhauser I, Berger M. Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 1993;36(February (2)):99-105.
15. Wilkinson CP, Ferris 3rd FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110(September (9)):1677-82.
16. KDOQI. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(February (2 (Suppl. 2))):S12-54.
17. Berger M, Mühlhauser I. Implementation of intensified insulin therapy: a European perspective. Diabet Med 1995;12(March (3)):201-8.
18. Assal JP. Bridges, why and from where to where? Patient Educ Couns 1995;26(September (1-3)):11-5.
19. Weinger K, Jacobson AM. Psychosocial and quality of life correlates of glycemic control during intensive treatment of type 1 diabetes. Patient Educ Couns 2001;42(February (2)):123-31.
20. Ismail K, Maissi E, Thomas S, Chalder T, Schmidt U, Bartlett J, et al. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent suboptimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess 2010;14(May (22)):1-101.
21. Hampson SE, Skinner TC, Hart J, Storey L, Gage H, Foxcroft D, et al. Behavioral interventions for adolescents with type 1 diabetes: how effective are they? Diabetes Care 2000;23(September (9)):1416-22.
22. Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, et al. Standards Revision Task Force. National standards for diabetes self-management education and support. Diabetes Care 2012;35(November (11)):2393-401.
23. Polak JF, Backlund JY, Cleary PA, Harrington AP, O'Leary DH, Lachin JM, et al. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes 2011;60(February (2)):607-13.
24. Raitakari OT, Juonala MRaitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003;290(November (17)):2277-83.
25. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 1999;48(April (4)):870-80.
26. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129-46.
27. Rathsman B, Rosfors S, Sjoholm A, Nystrom T. Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol 2012;11:145.